Literature DB >> 10744681

Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.

A van der Spoel1, E Bonten, A d'Azzo.   

Abstract

Lysosomal beta-D-galactosidase (beta-gal), the enzyme deficient in the autosomal recessive disorders G(M1) gangliosidosis and Morquio B, is synthesized as an 85-kDa precursor that is C-terminally processed into a 64-66-kDa mature form. The released approximately 20-kDa proteolytic fragment was thought to be degraded. We now present evidence that it remains associated to the 64-kDa chain after partial proteolysis of the precursor. This polypeptide was found to copurify with beta-gal and protective protein/cathepsin A from mouse liver and Madin-Darby bovine kidney cells and was immunoprecipitated from human fibroblasts but not from fibroblasts of a G(M1) gangliosidosis and a galactosialidosis patient. Uptake of wild-type protective protein/cathepsin A by galactosialidosis fibroblasts resulted in a significant increase of mature and active beta-gal and its C-terminal fragment. Expression in COS-1 cells of mutant cDNAs encoding either the N-terminal or the C-terminal domain of beta-gal resulted in the synthesis of correctly sized polypeptides without catalytic activity. Only when co-expressed, the two subunits associate and become catalytically active. Our results suggest that the C terminus of beta-gal is an essential domain of the catalytically active enzyme and provide evidence that lysosomal beta-galactosidase is a two-subunit molecule. These data may give new significance to mutations in G(M1) gangliosidosis patients found in the C-terminal part of the molecule.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744681     DOI: 10.1074/jbc.275.14.10035

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human β-galactosidase.

Authors:  Kimihito Usui; Umeharu Ohto; Toshinari Ochi; Toshiyuki Shimizu; Yoshinori Satow
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

2.  Broad-range glycosidase activity profiling.

Authors:  Balakumaran Chandrasekar; Thomas Colby; Asif Emran Khan Emon; Jianbing Jiang; Tram Ngoc Hong; Joji Grace Villamor; Anne Harzen; Herman S Overkleeft; Renier A L van der Hoorn
Journal:  Mol Cell Proteomics       Date:  2014-07-23       Impact factor: 5.911

Review 3.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

4.  The effect of Triaenophorus nodulosus (Cestoda: Bothriocephalidea) infection on some biochemical parameters of the liver of Perca fluviatilis.

Authors:  Ekaterina V Borvinskaya; Irina V Sukhovskaya; Lev P Smirnov; Albina A Kochneva; Aleksey N Parshukov; Marina Yu Krupnova; Elizaveta A Buoy; Rimma U Vysotskaya; Maria V Churova
Journal:  J Parasit Dis       Date:  2019-06-05

5.  Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency

Authors:  Amanda R Luu; Cara Wong; Vishal Agrawal; Nathan Wise; Britta Handyside; Melanie J Lo; Glenn Pacheco; Jessica B Felix; Alexander Giaramita; Alessandra d'Azzo; Jon Vincelette; Sherry Bullens; Stuart Bunting; Terri M Christianson; Charles M Hague; Jonathan H LeBowitz; Gouri Yogalingam
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

6.  Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.

Authors:  Umeharu Ohto; Kimihito Usui; Toshinari Ochi; Kenjiro Yuki; Yoshinori Satow; Toshiyuki Shimizu
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

7.  Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization.

Authors:  Erik J Bonten; Yvan Campos; Viateslav Zaitsev; Amanda Nourse; Brett Waddell; William Lewis; Garry Taylor; Alessandra d'Azzo
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

8.  Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient.

Authors:  Anna Caciotti; Tiziana Bardelli; John Cunningham; Alessandra D'Azzo; Enrico Zammarchi; Amelia Morrone
Journal:  Hum Genet       Date:  2003-03-19       Impact factor: 4.132

9.  Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity.

Authors:  Chi-Fan Yang; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-09-30       Impact factor: 8.410

10.  Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice.

Authors:  Xudong Wu; Katherine A Steigelman; Erik Bonten; Huimin Hu; Wenxuan He; Tianying Ren; Jian Zuo; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2009-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.